Plaintiffs allege that Novo Nordisks marketing campaign misled consumers by focusing on the benefits of weight loss while downplaying the potential for severe health risks, including intestinal blockages and stomach paralysis
By: Mike Montemarano Associate Editor, Nutraceuticals World Researchers from nutraceutical retailer GNC recently published a new peer-reviewed article in Obesity Pillars highlighting supplements that may be suitable to support those who are taking GLP-1 receptor agonists, such as Ozempic or Wegovy
Higher maintenance doses required for optimal effect typically increase monthly expenditure
Messer says, the amount of weight loss well see clinically with retatrutide will probably exceed what researchers saw in the trial. Some doctors tell me they expect the drug to outperform even bariatric surgery, leading to more weight loss in less time
Clinicians should recognize that patients undergoing polypharmacy require heightened vigilance, comprehensive monitoring, and specialized counseling
Highlights of prescribing information: Mounjaro
